Recognizing and Addressing Burnout Among GI Providers
14:00
Recognizing and Addressing Burnout Among GI Providers
4 сағат бұрын
Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enha...
1:00:00
Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enha...
7 сағат бұрын
Enhancing Outcomes in Relapsed/Refractory B-ALL with CAR T-Cell Therapy
12:30
Enhancing Outcomes in Relapsed/Refractory B-ALL with CAR T-Cell Therapy
9 сағат бұрын
Patient-Centric Approaches to Optimizing Outcomes in AAD: Case Review
15:00
Patient-Centric Approaches to Optimizing Outcomes in AAD: Case Review
12 сағат бұрын
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
59:30
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
21 сағат бұрын
Advancing Cystic Fibrosis: Addressing Disparities, Challenging Perceptions, and Innovating Patien...
1:05:00
Advancing Cystic Fibrosis: Addressing Disparities, Challenging Perceptions, and Innovating Patien...
21 сағат бұрын
Poster Pearl: Comparing the Efficiency of Stool-Based CRC Screening Tests
5:30
Poster Pearl: Comparing the Efficiency of Stool-Based CRC Screening Tests
Күн бұрын
Poster Pearl: Comparing Endorsed vs. Non-Endorsed CRC Screening Tests
5:30
Poster Pearl: Comparing Endorsed vs. Non-Endorsed CRC Screening Tests
Күн бұрын
Implementing the AMA MAPTM Hypertension Program: A Clinician’s Experience
10:00
Implementing the AMA MAPTM Hypertension Program: A Clinician’s Experience
Күн бұрын
Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Can...
55:30
Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Can...
Күн бұрын
Navigating COPD: From Symptom Recognition to Emerging Treatment Strategies
17:30
Navigating COPD: From Symptom Recognition to Emerging Treatment Strategies
14 күн бұрын
Navigating COPD: From Symptom Recognition to Emerging Treatment Strategies
17:30
Navigating COPD: From Symptom Recognition to Emerging Treatment Strategies
14 күн бұрын
The Evolving Role of MET TKIs in NSCLC
30:30
The Evolving Role of MET TKIs in NSCLC
14 күн бұрын
Momelotinib vs. Ruxolitinib: Comparing Efficacy in Myelofibrosis and Anemia Patients
3:30
Momelotinib vs. Ruxolitinib: Comparing Efficacy in Myelofibrosis and Anemia Patients
14 күн бұрын
Chairperson's Perspective: Redefining Treatment Across the Spectrum of HR+/HER2-Expressing Metast...
16:30
Chairperson's Perspective: Redefining Treatment Across the Spectrum of HR+/HER2-Expressing Metast...
14 күн бұрын
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
14:30
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
14 күн бұрын
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
14:30
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
14 күн бұрын
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
14:30
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
14 күн бұрын
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment ...
15:00
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment ...
21 күн бұрын
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and...
1:10:00
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and...
21 күн бұрын
Noncovalent BTK Inhibitors: New Targeted Options for Relapsed or Refractory Chronic Lymphocytic L...
44:30
Noncovalent BTK Inhibitors: New Targeted Options for Relapsed or Refractory Chronic Lymphocytic L...
21 күн бұрын
How Antibody-Based Therapies Are Revolutionizing Its Management
14:00
How Antibody-Based Therapies Are Revolutionizing Its Management
Ай бұрын
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
3:00
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Ай бұрын
Targeting Resistance in EGFRm NSCLC with HER3-Directed ADCs in the Community Setting
27:30
Targeting Resistance in EGFRm NSCLC with HER3-Directed ADCs in the Community Setting
Ай бұрын
Insights from ICARUS-Lung01: Efficacy and Safety of Dato-DXd for NSCLC
12:30
Insights from ICARUS-Lung01: Efficacy and Safety of Dato-DXd for NSCLC
Ай бұрын
Insights from ICARUS-Lung01: Efficacy and Safety of Dato-DXd for NSCLC
12:30
Insights from ICARUS-Lung01: Efficacy and Safety of Dato-DXd for NSCLC
Ай бұрын
Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers
5:30
Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers
Ай бұрын
Diversity in HER2 Expression Among Gynecologic Cancers
4:30
Diversity in HER2 Expression Among Gynecologic Cancers
Ай бұрын
Patient Case: How Do HER2-Directed Therapies Fit Into the Biliary Tract Cancer Treatment Landscape?
5:00
Patient Case: How Do HER2-Directed Therapies Fit Into the Biliary Tract Cancer Treatment Landscape?
Ай бұрын
Пікірлер